Skip to main content
Caplight Logo









Nebula Biocides GmbH

Nebula Biocides GmbH

Private
GreifswaldHealthcare & Life Scienceshttps://nebula-biocides.de/DE/

Last Round

Grant

Oct 1, 2023

Total Funding Raised

$2.37M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nebula Biocides GmbH is a biotechnology company that develops disinfection processes and products, including the Sporosan®-technology, designed to provide effective protection against infectious pathogens.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Quality Management

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

disinfectionbiotechnologyperoxynitrous acidONOOHdecontaminationhospital grade disinfectantpathogen eliminationmedical hygieneinfection controlindustrial hygieneclinical disinfectionbio-decontaminationsporicidehygiene consultingmedical device reprocessing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nebula Biocides GmbH Comparables

Compare Nebula Biocides GmbH with similar companies based on industry and business-model similarity.

Nebula Biocides GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TOMI Environmental Solutions
70%
Paul Hartmann AG
69%
Schülke & Mayr GmbH
68%

Nebula Biocides GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 1, 2023
SeedNov 10, 2021

Key People

Founding team and executive leadership

Katja Fricke

Chief Operating Officer und Qualitätsbeauftragte

Executive Team

Nebula Biocides GmbH Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors grew 233% MoM, from 52 to 173.

  • Apr 15, 2026

    Monthly visitors increased 187% MoM, from 254 to 728.

Nebula Biocides GmbH Filings

Explore SEC and related filing metadata, where available.

Nebula Biocides GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nebula Biocides GmbH's valuation, stock price, and market status.

Is Nebula Biocides GmbH a public or private company?

Nebula Biocides GmbH is a private company.

What is the current stock price of Nebula Biocides GmbH?

Nebula Biocides GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is Nebula Biocides GmbH worth (valuation)?

Valuation information for Nebula Biocides GmbH is not publicly available.

Can I buy Nebula Biocides GmbH stock?

Nebula Biocides GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nebula Biocides GmbH's last funding round?

Nebula Biocides GmbH's most recent funding round was Grant on October 1, 2023.

Who are the main investors in Nebula Biocides GmbH?

Key investors in Nebula Biocides GmbH include European Regional Development Fund, Mittelständische Beteiligungsgesellschaft Mecklenburg-Vorpommern mbH, High-Tech Gründerfonds, State of Mecklenburg-Vorpommern.

Will Nebula Biocides GmbH IPO soon?

No public IPO plans have been announced for Nebula Biocides GmbH.

How can I track Nebula Biocides GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nebula Biocides GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGreifswald
Employee Range3
Year Founded2019
Last FundingOct 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?